FindTrial
Sign In

Efficacy and Safety of Dabigatran for Thromboprophylaxis after Total Knee Arthroplasty

Efficacy and Safety of Dabigatran for Thromboprophylaxis after Total Knee Arthroplasty in Thai Patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
TCTR
Registry ID
TCTR20160208001
Enrollment
Unknown
Registered
2016-02-08
Start date
2016-03-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients underwent knee replacement surgery dabigatran&#44

Interventions

oral dabigatran after knee replacement surgery for 14 days for DVT prophylaxis,no anticoagulant prophylaxis after surgery
Experimental Drug,No Intervention No treatment
Prophylaxis group,No prophylaxis group

Sponsors

Golden Jubilee Medical Center, Mahidol University
Lead Sponsor
Golden Jubilee Medical Center&#44
Collaborator
Mahidol University
Collaborator

Eligibility

Sex/Gender
All
Age
50 Years to 85 Years

Inclusion criteria

Inclusion criteria: patients who underwent knee replacement surgery

Exclusion criteria

Exclusion criteria: allergic to dabigatran history of previous DVT&#44; history of abnormal bleeding within 1 year eGFR < 50 ml/min abnormal bleeding time

Design outcomes

Primary

MeasureTime frame
Deep vein thrombosis 7 day after surgery Doppler ultrasonography,Major bleeding complication 7 day after surgery Clinical examination—

Secondary

MeasureTime frame
Minor bleeding complication 7 day after surgery Clinical examination—

Countries

Thailand

Contacts

Public ContactTawan Intiyanaravut

Golden Jubilee Medical Center

tawan.int@mahidol.ac.th0894476168

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026